| DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer E Galle, B Thienpont, S Cappuyns, T Venken, P Busschaert, M Van Haele, ... Clinical epigenetics 12, 1-19, 2020 | 74 | 2020 |
| A novel method for hydrophobin extraction using CO 2 foam fractionation system M Khalesi, T Venken, S Deckers, J Winterburn, Z Shokribousjein, ... Industrial Crops and Products 43, 372-377, 2013 | 50 | 2013 |
| An optimized MM/PBSA virtual screening approach applied to an HIV‐1 gp41 fusion peptide inhibitor T Venken, D Krnavek, J Münch, F Kirchhoff, P Henklein, M De Maeyer, ... Proteins: Structure, Function, and Bioinformatics 79 (11), 3221-3235, 2011 | 45 | 2011 |
| Combined Modeling and Biophysical Characterisation of CO2 Interaction with Class II Hydrophobins: New Insight into the Mechanism Underpinning Primary Gushing S Deckers, T Venken, M Khalesi, K Gebruers, Y Lorgouilloux, ... Journal of the American Society of Brewing Chemists 70 (4), 249-256, 2012 | 29 | 2012 |
| Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer S Naulaerts, A Datsi, DM Borras, A Antoranz Martinez, J Messiaen, ... Science Translational Medicine 15 (691), eadd1016, 2023 | 25 | 2023 |
| pKa modulation of the acid/base catalyst within GH32 and GH68: a role in substrate/inhibitor specificity? S Yuan, K Le Roy, T Venken, W Lammens, W Van den Ende, ... PLoS One 7 (5), e37453, 2012 | 25 | 2012 |
| Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6) L Loverix, I Vergote, P Busschaert, A Vanderstichele, B Boeckx, T Venken, ... Gynecologic Oncology 166, S51-S52, 2022 | 17 | 2022 |
| Mapping the binding interface between an HIV-1 inhibiting intrabody and the viral protein Rev T Vercruysse, E Boons, T Venken, E Vanstreels, A Voet, J Steyaert, ... PLoS One 8 (4), e60259, 2013 | 17 | 2013 |
| Identification of a Small Molecule That Modulates Platelet Glycoprotein Ib-von Willebrand Factor Interaction K Broos, M Trekels, RA Jose, J Demeulemeester, A Vandenbulcke, ... Journal of Biological Chemistry 287 (12), 9461-9472, 2012 | 17 | 2012 |
| Computational investigation of the HIV‐1 Rev multimerization using molecular dynamics simulations and binding free energy calculations T Venken, D Daelemans, M De Maeyer, A Voet Proteins: Structure, Function, and Bioinformatics 80 (6), 1633-1646, 2012 | 11 | 2012 |
| PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial L Loverix, I Vergote, P Busschaert, A Vanderstichele, T Venken, B Boeckx, ... European Journal of Cancer 188, 131-139, 2023 | 10 | 2023 |
| Rapid conformational fluctuations of disordered HIV-1 fusion peptide in solution T Venken, A Voet, M De Maeyer, G De Fabritiis, SK Sadiq Journal of Chemical Theory and Computation 9 (7), 2870-2874, 2013 | 10 | 2013 |
| Thermodynamic framework to assess low abundance DNA mutation detection by hybridization H Willems, A Jacobs, WW Hadiwikarta, T Venken, D Valkenborg, ... PloS one 12 (5), e0177384, 2017 | 9 | 2017 |
| Transcription factor NKX2–1 drives serine and glycine synthesis addiction in cancer E Heylen, P Verstraete, L Van Aerschot, SL Geeraerts, T Venken, ... British Journal of Cancer 128 (10), 1862-1878, 2023 | 8 | 2023 |
| Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer A Vanderstichele, P Busschaert, C Landolfo, S Olbrecht, A Coosemans, ... NPJ Genomic Medicine 7 (1), 30, 2022 | 8 | 2022 |
| Immunogenomic, single-cell and spatial dissection of CD8+T cell exhaustion reveals critical determinants of cancer immunotherapy S Naulaerts, DM Borras, AA Martinez, J Messiaen, Y Van Herck, L Gelens, ... BioRxiv, 2021.11. 22.468617, 2021 | 7 | 2021 |
| Interactions stabilizing the C-terminal helix of human phospholipid scramblase 1 in lipid bilayers: A computational study T Venken, AS Schillinger, E Fuglebakk, N Reuter Biochimica et Biophysica Acta (BBA)-Biomembranes 1859 (7), 1200-1210, 2017 | 7 | 2017 |
| d-Peptides as inhibitors of PR3-membrane interactions K Maximova, T Venken, N Reuter, J Trylska Biochimica et Biophysica Acta (BBA)-Biomembranes 1860 (2), 458-466, 2018 | 6 | 2018 |
| DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer. Clin Epigenetics 12: 27 E Galle, B Thienpont, S Cappuyns, T Venken, P Busschaert, M Van Haele, ... | 5 | 2020 |
| Computational Studies of the Active and Inactive Regulatory Domains of Response Regulator PhoP Using Molecular Dynamics Simulations XY Qing, H Steenackers, T Venken, M De Maeyer, A Voet Molecular informatics 36 (11), 1700031, 2017 | 5 | 2017 |
Arnout VoetHoofddocent (associate professor) KU Leuven在 kuleuven.be 的电子邮件经过验证
